Comparison

MLT-231 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 100 mg
Item no. HY-131902-100mg
Targets MALT1
CASRN 2682102-10-7
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
MLT-231 is a potent, highly selective allosteric MALT1 Inhibitor with an IC50 of 9 nM. MLT-231 specifically prevents endogenous BCL10 cleavage with IC50 of 160 nM. MLT-231 shows antitumor activity in an ABC-DLBCL type xenograft model in mouse[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
469.85
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 110 mg/mL (ultrasonic)
Pathway
Metabolic Enzyme/Protease; NF-κB
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close